Levocetirizine Dihydrochloride
- Product NDC
- 50090-5341
- Requested package NDC
- 50090-5341-1
- 11-digit product format
- 500905341
- Labeler code
- 50090
- Product ID
- 50090-5341_ec104719-030c-4cd3-bdf8-09e2ce339eb8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Levocetirizine Dihydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA213513
- Marketing category
- ANDA
- Marketing start
- 2020-10-28
- Marketing end
- 0000-00-00
- Substance
- LEVOCETIRIZINE DIHYDROCHLORIDE
- Active strength
- 5 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50090-5341 | 50090-5341-1 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213513-001 | LEVOCETIRIZINE DIHYDROCHLORIDE | LEVOCETIRIZINE DIHYDROCHLORIDE | 5MG | TABLET / ORAL | 2020-04-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A213513-001 | LEVOCETIRIZINE DIHYDROCHLORIDE | 5MG | TABLET / ORAL | 2020-04-29 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Goodmeds Levocetirizine Dihydrochloride 5mg 365 count | LEVOCETIRIZINE DIHYDROCHLORIDE 5MG | Cabinet Health P.B.C. | 54f34304-952e-2f07-e063-6394a90a80ee | 2026-06-23 | Warnings | 213513 ANDA213513 |
| Levocetirizine Dihydrochloride | LEVOCETIRIZINE DIHYDROCHLORIDE | Farmacias De Similares TX LLC | 4ed17484-5609-d993-e063-6294a90a82a2 | 2026-04-06 | Warnings | 213513 ANDA213513 |
| Curist Allergy Relief | LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG | Little Pharma, Inc. | f2a2a5bc-2efa-c550-e053-2a95a90a55ff | 2026-03-05 | Warnings | 213513 ANDA213513 |
| Levocetirizine Dihydrochloride | LEVOCETIRIZINE DIHYDROCHLORIDE | Sportpharm LLC | 8c00c74f-4377-4f2c-943e-e55afa5a824f | 2026-02-14 | 213513 ANDA213513 | |
| ALLERGY RELIEF | LEVOCETIRIZINE DIHYDROCHLORIDE | YYBA CORP | 8ee69332-742d-4071-95df-84bc42e170e7 | 2025-12-03 | Warnings | 213513 ANDA213513 |
| Curist Allergy Relief | LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG | Little Pharma, Inc. | feabf140-e283-dcd5-e053-6394a90a2917 | 2025-04-16 | Warnings | 213513 ANDA213513 |
| Allery Relief 24HR | ALLERY RELIEF 24HR | Allegiant Health | c523c210-b1c4-4049-9c72-2b31c9c93137 | 2024-04-02 | Warnings | 213513 ANDA213513 |
| Levocetirizine Dihydrochloride | LEVOCETIRIZINE DIHYDROCHLORIDE | Camber Consumer Care Inc | be72dafb-62ae-40b2-874f-1d8920fad19d | 2020-11-30 | 213513 ANDA213513 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 36cf9111-9cc4-8f59-a74c-0c1cfbd4a760 | Product name | 7 | 20190702 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-5341-0 | 2023-01-30 | C162847 | 48780-1 | f386c64a-328b-0266-e053-dadaa90a7c1a | Levocetirizine Dihydrochloride Tablets USP, 5 mg (OTC) |
| 50090-5341-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-328b-0266-e053-dadaa90a7c1a | Levocetirizine Dihydrochloride Tablets USP, 5 mg (OTC) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5341-0 | Levocetirizine Dihydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 | |
| 50090-5341-1 | Levocetirizine Dihydrochloride | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5341 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 3 | Legacy NDC, 2 package rows | 20210417_3fad12b0-1bff-4899-99bb-0608b42d3be3.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 855172 | levocetirizine dihydrochloride 5 MG Oral Tablet | PSN | 3fad12b0-1bff-4899-99bb-0608b42d3be3 | 3 |
| 855172 | levocetirizine dihydrochloride 5 MG Oral Tablet | SCD | 3fad12b0-1bff-4899-99bb-0608b42d3be3 | 3 |
| 855172 | levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet | SY | 3fad12b0-1bff-4899-99bb-0608b42d3be3 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-5341-1 | 50090534101 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5341-1) | 2020-11-04 | 0000-00-00 | No | No | Current |